ArticleFrontiers in immunology2021

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.

Jian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.